BWX Technologies (BWXT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
8 Jul, 2026Executive summary
Q3 2024 revenue rose 14% year-over-year to $672 million, driven by strong organic growth in Government Operations and stable Commercial Operations.
Adjusted EBITDA increased 19% to $127 million, and non-GAAP EPS rose 24% to $0.83, reflecting margin expansion and lower corporate expenses.
Net income for Q3 2024 was $69.5 million, up from $60.3 million in Q3 2023; diluted GAAP EPS was $0.76.
Announced acquisition of AOT/A.O.T./Aerojet Ordinance Tennessee for ~$98–$100 million, expected to close by year-end, expanding the special materials portfolio and expected to be accretive to EPS.
Key contract wins include a pilot plant for domestic uranium enrichment and selection for HALEU deconversion services.
Financial highlights
Q3 2024 revenue: $672 million, up from $590 million in Q3 2023; adjusted EBITDA: $127 million (18.9% margin); non-GAAP EPS: $0.83.
Net income for Q3 2024 was $69.5 million; operating income was $96.6 million, up from $85.4 million in Q3 2023.
Free cash flow for Q3 2024 was negative at $(7.7)–$(8) million, impacted by contract timing and higher working capital needs.
Dividend of $0.24 per share paid in Q3 2024.
Working capital increased to $545.5 million as of September 30, 2024.
Outlook and guidance
2024 non-GAAP/adjusted EPS guidance raised to ~$3.20; free cash flow guidance maintained at $225–$250 million.
2025 outlook projects mid- to high-single-digit growth in revenue, adjusted EBITDA, and EPS, with at least 10% free cash flow growth.
Consolidated revenue guidance for 2024 raised to ~$2.7 billion.
48% of backlog revenue expected to be recognized by end of 2025.
Sufficient liquidity and borrowing capacity to meet cash requirements for the next 12 months and beyond.
Latest events from BWX Technologies
- Q2 2026 revenue up 18% to $901.6M, Commercial Ops up 72%, and guidance raised for the year.BWXT
Q2 20263 Aug 2026 - Record revenue, backlog, and free cash flow in 2024 support a strong 2025 growth outlook.BWXT
Q4 20249 Jul 2026 - Q1 2026 saw 26% revenue growth, higher earnings, record backlog, and raised guidance.BWXT
Q1 20265 May 2026 - Record 2025 growth and backlog set stage for robust 2026 gains across all key metrics.BWXT
Q4 202510 Apr 2026 - 2026 outlook projects high-teens revenue growth and double-digit free cash flow, fueled by nuclear demand.BWXT
Investor presentation18 Mar 2026 - Virtual annual meeting to elect directors, approve pay, and ratify auditor on April 30, 2026.BWXT
Proxy Filing18 Mar 2026 - Q2 2024 delivered double-digit growth and a higher EPS outlook amid strong industry demand.BWXT
Q2 20242 Feb 2026 - $525M acquisition expands nuclear and isotope services, boosting global reach and workforce.BWXT
M&A Announcement10 Jan 2026 - Q1 2025 revenue up 13%, net income $75.5M, backlog $4.88B, 2025 outlook reaffirmed.BWXT
Q1 202525 Dec 2025